After the FDA crackdown, here’s how some companies are still selling GLP-1s
A new “microdosing” trend lets pharmacies offer compounded versions of GLP-1 drugs even after the FDA declared the shortage over.
Microdosing isn’t just about mushrooms any more.
What did you think of this news? Leave a comment below and/or share it on your social media. This way, we can inform more people about the hottest things in technology, science, innovation, and gaming!
This news was originally published in:
Original source
